Immunotherapy and the spectrum of kidney disease: should we individualize the treatment?

HIGHLIGHTS

  • who: Sheila Bermejo and Maria Joseu0301 Soler from the (UAB), Spain University of Firenze, Italy have published the research work: Immunotherapy and the Spectrum of Kidney Disease: Should We Individualize the Treatment?, in the Journal: (JOURNAL)
  • what: The ICI spectrum in kidney disease is wide, from its related immunotoxicity such as AIN and glomerulonephritis to their use in special populations, namely, dialysis and kidney transplant patients.
  • future: More studies are needed to evaluate the tolerance and the incidence of irAEs derived from ICIs in this population.

SUMMARY

    Cancer is . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?